| PERIOD ENDING | 30-Sep-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 494,711 | 437,355 | 349,205 | 109,702 | | Cost of Revenue | 446,085 | 294,716 | 231,534 | 66,153 | | | Gross Profit | 48,626 | 142,639 | 117,671 | 43,549 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,539 | 42,446 | 37,693 | 33,173 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 15,817 | 15,522 | 18,384 | 18,113 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (730) | 84,671 | 61,594 | (7,737) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,238 | 602 | 792 | 841 | | Earnings Before Interest And Taxes | 508 | 85,561 | 62,460 | (6,970) | | Interest Expense | 10,672 | 9,370 | 9,801 | 9,415 | | Income Before Tax | (10,164) | 76,191 | 52,659 | (16,385) | | Income Tax Expense | (3,431) | 28,828 | 19,479 | (6,265) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,733) | 47,363 | 33,180 | (10,120) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,733) | 47,363 | 33,180 | (10,120) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,733) | $47,363 | $33,180 | ($10,120) |
|
0.47% Nasdaq 
Income Statement
